IL-37 Expression is Upregulated in Patients with Tuberculosis and Induces Macrophages Towards an M2-like Phenotype

Scandinavian Journal of Immunology

Volumn 82, Issue 4, 2015, Pages 370-379

  Huang, Z ^a,b   Gao, C ^c   Chi, X ^d   Hu, Y W ^a   Zheng, L ^a   Zeng, T ^a   Wang, Q ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Central Hospital of Longgang District   (China)

^c LINYI PEOPLE'S HOSPITAL   (China)

^d GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; BIOLOGICAL MARKER; CD206 ANTIGEN; CD86 ANTIGEN; CELL ANTIGEN; ETHAMBUTOL; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 37; ISONIAZID; MESSENGER RNA; NITRIC OXIDE; PYRAZINAMIDE; RIFAMPICIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ARGINASE; ARGINASE I, HUMAN; CD86 PROTEIN, HUMAN; CELL SURFACE RECEPTOR; IL10 PROTEIN, HUMAN; IL12A PROTEIN, HUMAN; IL37 PROTEIN, HUMAN; INTERLEUKIN 1; INTERLEUKIN 12P35; LECTIN; MANNOSE BINDING LECTIN; MANNOSE RECEPTOR; SMALL INTERFERING RNA; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ACTIVITY; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; LUNG TUBERCULOSIS; MACROPHAGE ACTIVATION; MALE; MYCOBACTERIUM TUBERCULOSIS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; BIOSYNTHESIS; BLOOD; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; IMMUNOLOGY; MACROPHAGE; METABOLISM; MIDDLE AGED; RNA INTERFERENCE; TRANSCRIPTION INITIATION; TUBERCULOSIS, PULMONARY;

ANTIGENS, CD86; ANTITUBERCULAR AGENTS; ARGINASE; CELL DIFFERENTIATION; CELLS, CULTURED; ETHAMBUTOL; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-12 SUBUNIT P35; ISONIAZID; LECTINS, C-TYPE; MACROPHAGES; MALE; MANNOSE-BINDING LECTINS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE; PHAGOCYTOSIS; PHENOTYPE; PYRAZINAMIDE; RECEPTORS, CELL SURFACE; RIFAMPIN; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTIONAL ACTIVATION; TRANSFORMING GROWTH FACTOR BETA; TUBERCULOSIS, PULMONARY; UP-REGULATION;

EID: 84941088425     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12326     Document Type: Article

References (42)

1. Lienhardt C, Glaziou P, Uplekar M, Lonnroth K, Getahun H, Raviglione M. Global tuberculosis control: lessons learnt and future prospects. Nat Rev Microbiol 2012;10:407-16.
2. Dye C. Global epidemiology of tuberculosis. Lancet 2006;367:938-40.
3. Munk ME, Emoto M. Functions of T-cell subsets and cytokines in mycobacterial infections. Eur Respir J Suppl 1995;20:668s-75s.
4. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993;178:2249-54.
5. Cooper AM, Magram J, Ferrante J, Orme IM. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 1997;186:39-45.
6. Murray PJ, Young RA. Increased antimycobacterial immunity in interleukin-10-deficient mice. Infect Immun 1999;67:3087-95.
7. Beamer GL, Flaherty DK, Assogba BD et al. Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice. J Immunol 2008;181:5545-50.
8. Fulton SA, Cross JV, Toossi ZT, Boom WH. Regulation of interleukin-12 by interleukin-10, transforming growth factor-beta, tumor necrosis factor-alpha, and interferon-gamma in human monocytes infected with Mycobacterium tuberculosis H37Ra. J Infect Dis 1998;178:1105-14.
9. Toossi Z, Gogate P, Shiratsuchi H, Young T, Ellner JJ. Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions. J Immunol 1995;154:465-73.
10. Hirsch CS, Yoneda T, Averill L, Ellner JJ, Toossi Z. Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by transforming growth factor-beta 1. J Infect Dis 1994;170:1229-37.
11. Bonecini-Almeida MG, Ho JL, Boechat N et al. Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis. Infect Immun 2004;72:2628-34.
12. Kumar S, McDonnell PC, Lehr R et al. Identification and initial characterization of four novel members of the interleukin-1 family. J Biol Chem 2000;275:10308-14.
13. Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA. IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 2010;11:1014-22.
14. Gao W, Kumar S, Lotze MT, Hanning C, Robbins PD, Gambotto A. Innate immunity mediated by the cytokine IL-1 homologue 4 (IL-1H4/IL-1F7) induces IL-12-dependent adaptive and profound antitumor immunity. J Immunol 2003;170:107-13.
15. Zhao JJ, Pan QZ, Pan K et al. Interleukin-37 mediates the antitumor activity in hepatocellular carcinoma: role for CD57+ NK cells. Sci Rep 2014;4:5177.
16. Ye L, Ji L, Wen Z et al. IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity. J Transl Med 2014;12:69.
17. Li Y, Wang Y, Liu Y, Zuo X, Lu X. The possible role of the novel cytokines IL-35 and IL-37 in inflammatory bowel disease. Mediators Inflamm 2014;2014:136329.
18. Wan ZY, Sun Z, Song F et al. Downregulated interleukin 37 expression associated with aggravation of intervertebral disc degeneration. Int J Clin Exp Pathol 2014;7:656-62.
19. Li Y, Wang Z, Yu T et al. Increased expression of IL-37 in patients with Graves' disease and its contribution to suppression of proinflammatory cytokines production in peripheral blood mononuclear cells. PLoS One 2014;9:e107183.
20. Armstrong JA, Hart PD. Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J Exp Med 1975;142:1-16.
21. Benoit M, Desnues B, Mege JL. Macrophage polarization in bacterial infections. J Immunol 2008;181:3733-9.
22. Murray PJ, Wynn TA. Obstacles and opportunities for understanding macrophage polarization. J Leukoc Biol 2011;89:557-63.
23. Martinez FO. Regulators of macrophage activation. Eur J Immunol 2011;41:1531-4.
24. Schreiber T, Ehlers S, Heitmann L et al. Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity. J Immunol 2009;183:1301-12.
25. El Kasmi KC, Qualls JE, Pesce JT et al. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat Immunol 2008;9:1399-406.
26. Hajishengallis G, Lambris JD. Microbial manipulation of receptor crosstalk in innate immunity. Nat Rev Immunol 2011;11:187-200.
27. Bulau AM, Nold MF, Li S et al. Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses. Proc Natl Acad Sci U S A 2014;111:2650-5.
28. Hirota K, Tomoda K, Inagawa H et al. Stimulation of phagocytic activity of alveolar macrophages toward artificial microspheres by infection with mycobacteria. Pharm Res 2008;25:1420-30.
29. Mariani F, Goletti D, Ciaramella A, Martino A, Colizzi V, Fraziano M. Macrophage response to Mycobacterium tuberculosis during HIV infection: relationships between macrophage activation and apoptosis. Curr Mol Med 2001;1:209-16.
30. Ehrt S, Schnappinger D, Bekiranov S et al. Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J Exp Med 2001;194:1123-40.
31. Lugo-Villarino G, Verollet C, Maridonneau-Parini I, Neyrolles O. Macrophage polarization: convergence point targeted by Mycobacterium tuberculosis and HIV. Front Immunol 2011;2:43.
32. Skolimowska KH, Rangaka MX, Meintjes G et al. Altered ratio of IFN-gamma/IL-10 in patients with drug resistant Mycobacterium tuberculosis and HIV- Tuberculosis Immune Reconstitution Inflammatory Syndrome. PLoS One 2012;7:e46481.
33. Wu M, Aung H, Hirsch CS, Toossi Z. Inhibition of Mycobacterium tuberculosis-induced signalling by transforming growth factor-beta in human mononuclear phagocytes. Scand J Immunol 2012;75:301-4.
34. Cooper AM, Solache A, Khader SA. Interleukin-12 and tuberculosis: an old story revisited. Curr Opin Immunol 2007;19:441-7.
35. Banchereau J, Pascual V, O'Garra A. From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines. Nat Immunol 2012;13:925-31.
36. Gonzalez-Juarrero M, Shim TS, Kipnis A, Junqueira-Kipnis AP, Orme IM. Dynamics of macrophage cell populations during murine pulmonary tuberculosis. J Immunol 2003;171:3128-35.
37. Davis JM, Ramakrishnan L. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 2009;136:37-49.
38. 5Volkman HE, Pozos TC, Zheng J, Davis JM, Rawls JF, Ramakrishnan L. Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science 2010;327:466-9.
39. Dangaj D, Abbott KL, Mookerjee A et al. Mannose receptor (MR) engagement by mesothelin GPI anchor polarizes tumor-associated macrophages and is blocked by anti-MR human recombinant antibody. PLoS One 2011;6:e28386.
40. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009;29:13435-44.
41. Sica A, Larghi P, Mancino A et al. Macrophage polarization in tumour progression. Semin Cancer Biol 2008;18:349-55.
42. Liu G, Ma H, Qiu L et al. Phenotypic and functional switch of macrophages induced by regulatory CD4+CD25+ T cells in mice. Immunol Cell Biol 2011;89:130-42.